Rhythm Pharmaceuticals Inc —— 资产负债表 (NASDAQ:RYTM) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 187.07 M329.52 M382.48 M332.75 M392.27 M480.2 M 负债总额 20.55 M45.37 M118.22 M162.99 M227.72 M210.17 M 权益总额 166.53 M284.15 M264.26 M169.76 M21.73 M139.07 M 负债及股东权益总额 187.07 M329.52 M382.48 M332.75 M392.27 M480.2 M 总债务 ————109.81 M108.18 M 净债务 ————-210.75 M-280.72 M

新闻

Strength Seen in Rhythm Pharmaceuticals (RYTM): Can Its 12.6% Jump Turn into More Strength?

Rhythm Pharmaceuticals, Inc. (RYTM) Discusses FDA Approval of IMCIVREE for Acquired Hypothalamic Obesity - Slideshow (NASDAQ:RYTM) 2026-03-24

Rhythm Surges On A New Obesity Approval; How It Edged In Where Lilly, Novo 'Have Fallen Flat'

Rhythm Pharmaceuticals, Inc. (RYTM) Discusses FDA Approval of IMCIVREE for Acquired Hypothalamic Obesity Transcript

Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)

Rhythm Pharmaceuticals Misses The Beat In Obesity, But There's A Caveat

Needham因试验失败下调Rhythm Pharmaceuticals目标价

Needham cuts Rhythm Pharmaceuticals stock price target on trial miss

Rhythm Pharmaceuticals, Inc. (RYTM) Discusses Topline Results and Insights from Phase 3 EMANATE Trial - Slideshow (NASDAQ:RYTM) 2026-03-17

Rhythm Pharmaceuticals, Inc. (RYTM) Discusses Topline Results and Insights from Phase 3 EMANATE Trial Transcript

Rhythm Pharma shares fall as obesity drug trial fails to meet main goal

Stifel重申Rhythm Pharmaceuticals股票评级为买入